GE HealthCare GC receives new stock awards

GE HealthCare Technologies Inc. reported that its General Counsel and Corporate Secretary, Frank R. Jimenez, received new equity awards.

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. reported that its General Counsel and Corporate Secretary, Frank R. Jimenez, received new equity awards. He was granted an employee stock option covering 28,697 shares of common stock at an exercise price of $0.00 per share, and a separate award of 10,915 shares of common stock, reported as a grant or award acquisition.

The common stock award represents restricted stock units, each equal to one share of GE HealthCare common stock. For that award, 33% will vest on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029. The stock option vests on the same schedule, with 33% becoming exercisable on each of those first two dates and 34% on the third. After these transactions, Jimenez directly holds 28,697 employee stock options and 92,182 shares of common stock.

Insider Trade Summary

Grant/Award: 39,612 shares

Grant/Award 2 txns

Insider Jimenez Frank R

Role GC & Corporate Secretary

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	28,697	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share	10,915	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 28,697 contracts (Direct); Common Stock, par value $0.01 per share — 92,182 shares (Direct)

Footnotes (3)

1. F1. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.
2. F2. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.
3. F3. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did GEHC’s Frank R. Jimenez report on this Form 4?

Frank R. Jimenez reported receiving equity awards, not open-market trades. He was granted 28,697 employee stock options and 10,915 shares of GE HealthCare common stock as restricted stock units, all characterized as grant or award acquisitions on the transaction date.

How many GEHC stock options were granted to Frank R. Jimenez?

He received an employee stock option covering 28,697 shares of GE HealthCare common stock. The option was granted at a price of $0.00 per share and will vest in three tranches, with portions becoming exercisable in 2027, 2028, and 2029 under the award schedule.

What is the vesting schedule for Frank R. Jimenez’s restricted stock units at GEHC?

The restricted stock units vest in three stages over three years. Thirty-three percent vest on September 2, 2027, another 33% on September 2, 2028, and the remaining 34% on September 2, 2029, each representing the right to receive one GE HealthCare share.

What is the vesting schedule for the GEHC employee stock option granted to Jimenez?

The employee stock option vests over the same three-year period as the restricted stock units. Thirty-three percent becomes exercisable on September 2, 2027, another 33% on September 2, 2028, and the final 34% becomes exercisable on September 2, 2029, subject to award terms.

How many GEHC common shares does Frank R. Jimenez own after these transactions?

After the reported equity grants, he directly holds 92,182 shares of GE HealthCare common stock. This total reflects the addition of 10,915 granted shares reported on the Form 4, combined with previously held shares recorded in the ownership figure following the transaction.

Are Frank R. Jimenez’s GEHC equity awards open-market purchases or compensation grants?

They are compensation-related grants, not open-market purchases. Both transactions use code A, described as a grant, award, or other acquisition, covering 28,697 stock options and 10,915 restricted stock units of GE HealthCare common stock for the company’s General Counsel.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 04:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jimenez Frank R

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GC & Corporate Secretary

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	03/02/2026		A		10,915(1)(2)	A	$0	92,182	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$80.16	03/02/2026		A		28,697		(3)	03/02/2036	Common Stock, par value $0.01 per share	28,697	$0(3)	28,697	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

2. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

3. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Remarks:

	/s/ Frank R. Jimenez	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.